Mobile Menu - OpenMobile Menu - Closed

Hearing on “Examining the Reauthorization of the Pandemic and All-Hazards Preparedness Act,” Subcommittee on Health (June 6, 2018)

Date: 
Wednesday, June 6, 2018 - 10:00am
Location: 
2123 Rayburn House Office Building
Subcommittees: 

The Subcommittee on Health held a hearing on Wednesday, June 6, 2018, at 10:00 a.m. in 2123 Rayburn House Office Building. The hearing is entitled “Examining the Reauthorization of the Pandemic and All-Hazards Preparedness Act.”

 

Livestream

 

Key Documents

Memorandum from Ranking Member Pallone to the Subcommittee on Health

Opening Statement of Ranking Member Pallone as prepared for delivery

Opening Statement of Subcommittee Ranking Member Green as prepared for delivery

Preliminary Transcript

 

Legislation

H.R. __, Pandemic and All-Hazards Preparedness Reauthorization Act of 2018, To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, and for other purposes. 

 

Witnesses

Panel I:

Robert Kadlec, MD
Assistant Secretary for Preparedness and Response (ASPR)
U.S. Department of Health and Human Services

Testimony


Stephen Redd, MD, RADM
Director
Office of Public Health Preparedness and Response
Centers for Disease Control and Prevention (CDC)

Testimony


Anna Abram
Deputy Commissioner for Policy, Planning, Legislation, and Analysis
Food and Drug Administration (FDA)

Testimony

 

Panel II:

Erik Decker
Chief Security and Privacy Officer
University of Chicago Medicine

Testimony


M. Michelle Berrey, MD, MPH
President and CEO
Chimerix, Inc

Testimony


Umair Shah, MD, MPH
Executive Director
Harris County Public Health
President
National Association of County and City Health Officials (NACCHO) 

Testimony

Issues: